Should I buy Mettler Toledo (MTD) stock or is it too late?

Mettler Toledo · Health Care · price $1,407

See the full Mettler Toledo (MTD) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Jefferies — 72% of its targets hit on this sector (380 calls tested). It aims for $1,580 (+12 %), call made on August 1, 2026, maturing on August 1, 2027 (27 d ago).

The 5 reliable analysts $1,575+12 %

The 4 other firms $1,350-4.1 %

How to read it: the 5 reliable firms are not filtered by optimism — 5 aim above the price, 0 below, hence their $1,575 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Mettler Toledo

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
B of A Securities	80 %	+22.9 %	5	$1,390 -1%
Citigroup	83 %	+10.1 %	6	$1,550 +10%
Wells Fargo	50 %	+0.3 %	6	$1,450 +3%
Stifel	40 %	-0.5 %	5	$1,600 +14%
Evercore ISI Group	80 %	-6.0 %	5	$1,500 +7%
UBS	43 %	-16.4 %	7	$1,350 -4%

In short — Should you invest in Mettler Toledo? Is it too late, still worth it? Analysts are fairly positive (56% buy, median target $1,500, i.e. +7%), and the most reliable on MTD targets even higher. But the valuation is stretched (P/E ~32), it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

The most reliable firm on MTD, Jefferies (100% hit rate, 3 scored calls), targets $1,580 (call made on July 31, 2026, maturing on July 31, 2027) (+12%) in its most recent call, and $1,450 (call made on March 20, 2026, maturing on March 20, 2027) (+3%) in the one coming due soonest.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 9 ratings, 4 are neutral.
Limited upside: the median target is only +7% from the current price.
High valuation (P/E ~32): strong growth is already "priced in", leaving little room for error.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
No dividend: your return depends only on price appreciation.

The analyst consensus on MTD

Median target $1,500 (+7%) · 9 ratings · Buy consensus

Strong Buy00%

Buy556%

Hold444%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Mettler Toledo now?

We won't decide for you. The facts: 56% of analysts rate it a buy, median target $1,500 (+7%), and Jefferies (most reliable on MTD, 100%) targets $1,580. Weigh that against valuation (P/E ~32). This is not personalized advice.

Is it too late to invest in Mettler Toledo?

Not according to analysts: the median target ($1,500) is still +7% above the current price ($1,407) (most reliable on MTD: Jefferies, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Mettler Toledo still worth investing in?

It depends on the gap between the price ($1,407) and its estimated value: analysts target $1,500 on median (+7%), with 56% buys (most reliable on MTD: Jefferies, 100%). Cross-check with their real reliability on MTD and the cautions above. Information, not advice.

What's the main risk in buying MTD?

The consensus is not unanimous: of 9 ratings, 4 are neutral.

→ Go deeper: the full Mettler Toledo profile (consensus, analyst reliability, price target, performance).